scout
|Videos|August 9, 2016

The Role of PARP Inhibitors in Prostate Cancer

Christopher E. Barbieri, MD, PhD, surgeon, researcher in prostate cancer, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and New-York Presbyterian, discusses the role of PARP inhibitors in castration-resistant prostate cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME